Morwell Pharmacia Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 46.50%
- Profit Growth 215.92%
- Ebitda -259.12%
- Net Worth 12.80%
- Total Assets 22.51%
About Morwell Pharmacia
Morwell Pharmacia Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 December 2010 and has a history of 14 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manoj Patni, Chetan Patni, and Apoorv Patni serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100DL2010PTC211570
- Company No.
211570
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Morwell Pharmacia Private Limited offer?
Morwell Pharmacia Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Cardiovascular Drugs & Medication, Cholesterol Medicine.
Who are the key members and board of directors at Morwell Pharmacia?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Patni  | Director | 17-Oct-2013 | Current |
| Manoj Patni | Director | 20-Dec-2010 | Current |
| Apoorv Patni | Director | 17-Oct-2013 | Current |
Financial Performance of Morwell Pharmacia.
Morwell Pharmacia Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 46.5% increase. The company also saw a substantial improvement in profitability, with a 215.92% increase in profit. The company's net worth Soared by an impressive increase of 12.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morwell Pharmacia?
In 2019, Morwell Pharmacia had a promoter holding of 5.00% and a public holding of 95.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarawgi Holdings Private LimitedManoj Patni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Morwell Pharmacia?
Unlock and access historical data on people associated with Morwell Pharmacia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morwell Pharmacia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morwell Pharmacia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
